Professor of Medicine, University Miami School of Medicine
Gastroenterology
Dr. Maria T. Abreu, MD
|
|
Give Review
Maria Abreu practices Gastroenterology. She attended University of Miami Miller School of Medicine. University of Miami Miller School of Medicine is ranked 45/0 in Research/PrimaryCare. She received awards:"America's Top Doctors", "Top Doctors:South Florida", "CMS Meaningful Use Stage 1 Certification", "Fellow (AGAF)", "Elected Member", "Top Doctors: New York Metro Area" and "Super Doctor". Maria Abreu is a published physician. She published 98 publications, including: 'Use of Cancer Stem Cells to Investigate the Pathogenesis of Colitis-associated Cancer.' Dr. Maria T. Abreu is registered with Medicare and accepts Medicare payments.
Publications
- Use of Cancer Stem Cells to Investigate the Pathogenesis of Colitis-associated Cancer.
- Higher Adalimumab Levels Are Associated with Histologic and Endoscopic Remission in Patients with Crohn's Disease and Ulcerative Colitis.
- Deciphering the Genetic Code of Gastrointestinal Diseases Among African Americans.
- The association of tissue anti-TNF drug levels with serological and endoscopic Disease activity in inflammatory bowel Disease: the ATLAS study.
- The innate immune System and inflammatory bowel disease.
- Concentrations of 6-Thioguanine Nucleotide Correlate With Trough Levels of Infliximab in Patients With Inflammatory Bowel Disease on Combination Therapy.
- Host-microbe interactions in the small bowel.
- Therapeutic drug monitoring in patients with inflammatory bowel Disease.
- The incidence and risk factors for developing depression after being diagnosed with inflammatory bowel Disease: a cohort study.
- Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids.
- Increased toll-like receptor 4 in cerebral endothelial cells contributes to the astrocyte swelling and brain edema in acute hepatic encephalopathy.
- Exercise Attenuates PCB-Induced Changes in the Mouse Gut Microbiome.
- The Impact of Hispanic Ethnicity and Race on Post-Surgical Complications in Patients with Inflammatory Bowel Disease.
- Placental Transfer of Anti-Tumor Necrosis Factor Agents in Pregnant Patients with Inflammatory Bowel Disease.
- Phenotypic manifestations of inflammatory bowel Disease differ between hispanics and non-Hispanic whites: results of a large cohort study.
- Update on idiopathic colitides.
- Genetics in diagnosing and managing inflammatory bowel Disease.
- Cancer in inflammatory bowel disease: lessons from animal models.
- Innate immunity in the small intestine.
- Response to raftery and o'sullivan.
- Developing an instrument to assess the endoscopic severity of Ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS).
- Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis.
- Aberrant expression of the polarity complex atypical PKC and non-muscle myosin IIA in active and inactive inflammatory bowel Disease.
- Corrigendum: antibiotic therapy in inflammatory bowel disease: a Systematic review and meta-analysis.
- Inflammatory bowel Disease is associated with an increased incidence of cardiovascular events.
- Glucocorticosteroid therapy in inflammatory bowel disease: Systematic review and meta-analysis.
- Antibiotic therapy in inflammatory bowel disease: a Systematic review and meta-analysis.
- Anti-TNF failures in Crohn's Disease.
- Mesalamine (5-aminosalicylic acid) therapy well tolerated in a patient with aspirin hypersensitivity and Ulcerative colitis.
- Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to Intestinal mucosal injury.
- Certolizumab pegol in patients with moderate to severe Crohn's Disease and secondary failure to infliximab.
- Combination of innate and adaptive immune alterations increased the likelihood of fibrostenosis in Crohn's Disease.
- Re: underrepresentation of underrepresented minorities in academic medicine.
- Microflora in Colorectal cancer: a friend to fear.
- Clinical outcomes of patients with Ulcerative colitis and co-existing Clostridium difficile infection.
- The Ying and Yang of bacterial signaling in necrotizing enterocolitis.
- Regulation of Toll-like receptor 4-associated MD-2 in Intestinal epithelial cells: a comprehensive analysis.
- FcRL3 gene promoter variant is associated with peripheral arthritis in Crohn's Disease.
- Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors.
- A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis.
- Practical techniques for detection of Toll-like receptor-4 in the human intestine.
- What are toll-like receptors and what role may they have in IBD?
- What is the role and significance of serum and stool biomarkers in the diagnosis of IBD?
- Harnessing the power of bacteria to protect the gut.
- Toll-like receptor signaling in small Intestinal epithelium promotes B-cell recruitment and IgA production in lamina propria.
- Combination therapy with infliximab and immunomodulators: is the glass half empty?
- How are Azathioprine and 6-mercaptopurine dosed by gastroenterologists? Results of a survey of clinical practice.
- Gut microbes in Crohn's Disease: getting to know you better?
- The myeloid differentiation factor 88 (MyD88) is required for CD4+ T cell effector function in a murine model of inflammatory bowel Disease.
- Role of vascular endothelial growth factor and angiopoietin Systems in serum of Crohn's disease patients.
- Toll-like receptor-4 promotes the development of colitis-associated Colorectal tumors.
- Hepatotoxicity of 6-mercaptopurine (6-MP) and Azathioprine (AZA) in adult IBD patients.
- Selective leukocyte apheresis for the treatment of inflammatory bowel Disease.
- Anti-flagellin (CBir1) phenotypic and genetic Crohn's Disease associations.
- The multimatrix mesalamine formulation.
- Diagnosis of colitis: making the initial diagnosis.
- NOD2 variants and antibody response to microbial antigens in Crohn's Disease patients and their unaffected relatives.
- Crohn's Disease in patients who fail infliximab therapy: what does the future hold?
- Antibodies to I2 predict clinical response to fecal diversion in Crohn's Disease.
- Translational research in inflammatory bowel Disease.
- Advances in the pathogenesis of inflammatory bowel Disease.
- Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine.
- Serologies in Crohn's Disease: can we change the gray zone to black and white?
- Use of capsule endoscopy for established Crohn's Disease.
- Treatment with infliximab is associated with increased markers of bone formation in patients with Crohn's Disease.
- Design issues and outcomes in IBD clinical trials.
- Nod2 in normal and abnormal Intestinal immune function.
- Toll-like receptor-4 is required for Intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis.
- TLR signaling in the gut in health and Disease.
- Safety and efficacy of adalimumab (D2E7) in Crohn's Disease patients with an attenuated response to infliximab.
- Ulcerative colitis therapy: importance of delivery mechanisms.
- New insights into the pathogenesis of inflammatory bowel Disease.
- Beta-defensin-2 expression is regulated by TLR signaling in Intestinal epithelial cells.
- Early hepatic nodular hyperplasia and submicroscopic fibrosis associated with 6-thioguanine therapy in inflammatory bowel Disease.
- The spectrum of gastrointestinal toxicity and effect on Disease activity of selective cyclooxygenase-2 inhibitors in patients with inflammatory bowel Disease.
- A pilot study of adalimumab in infliximab-allergic patients.
- Biomarkers in inflammatory bowel Disease.
- Choosing Therapy on the Basis of Disease Classifications in Inflammatory Bowel Disease.
- Innate immunity and toll-like receptors: clinical implications of basic science research.
- Is genetic testing in IBD ready for prime time?
- Immunologic regulation of toll-like receptors in gut epithelium.
- 6-thioguanine can cause serious liver injury in inflammatory bowel Disease patients.
- Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine.
- Human Intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut.
- Defining subtypes of Crohn's Disease patients: the ground work for translational research in inflammatory bowel Disease.
- The pathogenesis of inflammatory bowel Disease: translational implications for clinicians.
- Mutations in NOD2 are associated with fibrostenosing Disease in patients with Crohn's Disease.
- TLR4 and MD-2 expression is regulated by immune-mediated signals in human Intestinal epithelial cells.
- Controversies in IBD. Serologic tests are helpful in managing inflammatory bowel Disease.
- 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel Disease.
- Development of Advanced Imaging Criteria for the Endoscopic Identification of Inflammatory Polyps.
- Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel Disease patients: a prospective endo...
- Extracorporeal photopheresis for the treatment of refractory Crohn''s Disease: results of an open-label pilot study.
- An evidence-based Systematic review on medical therapies for inflammatory bowel disease.
- Antibodies to tumor necrosis factor-alpha in the treatment of Crohn''s Disease.
- Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders.
- Evaluation of 22 genetic variants with Crohn''s Disease risk in the Ashkenazi Jewish population: a case-control study.
Schools
University Of Miami School Of Medicine
Brigham and Women39s Hospital
University Of California Los Angeles
University Of Miami
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- ERCP (Endoscopic Retrograde Cholangiopancreatography)
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:South Florida
- CMS Meaningful Use Stage 1 Certification
- Fellow (AGAF)
- Elected Member
- Top Doctors: New York Metro Area
- Super Doctor
Education
-
UCLA Medical Center -
Brigham and Women's Hospital -
University of Miami Miller School of Medicine
Hospital
-
University of Miami Hospital -
Miami Veterans Affairs Healthcare System
Drug Facts
| NPI NUMBER | 1598793374 | |
| NPPES Provider LastName | ABREU | |
| NPPES Provider FirstName | MARIA | |
| NPPES Provider ZIPCode | 331381028 | |
| NPPES Provider State | FL | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 657.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1598793374 |
| Last Name Of The Provider | ABREU |
| First Name Of The Provider | MARIA |
| View All |
Similar Doctors
|
|
Dr. Geoffrey Jones, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Jerry Martel, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. S L. Rothman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Roberto R. Gonzalez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven J. Price, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adam L. Peyton, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marcelo F. Larsen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pedro J. Ramos, MD |